skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8129

Erratum: An economic evaluation of aripiprazole vs olanzapine adapted to the Italian setting using outcomes of metabolic syndrome and risk for diabetes in patients with schizophrenia. Neuropsychiatr Dis Treat, 4: 967–976

Other

(2002) Views  (407) Full article downloads

Authors: Colombo GL, Caruggi M, Di Matteo, et al

Published Date February 2009 Volume 2008:4(6) Pages 1283 - 1283
DOI: http://dx.doi.org/10.2147/NDT.S5342

Erratum

Colombo GL, Caruggi M, Di Matteo, et al. 2008. An economic evaluation of aripiprazole vs olanzapine adapted to the Italian setting using outcomes of metabolic syndrome and risk for diabetes in patients with schizophrenia. Neuropsychiatr Dis Treat, 4: 967–976.

Page 972, Results, right column, last paragraph. The second sentence should read:

In the simulated cohort of 1000 patients, the values with aripiprazole for 26 weeks showed the avoidance of 34 events of diabetes over 5 years (28 in discounted scenario), resulting in total cost savings of €1,933.24 (€1,472.52 in discounted scenario).

Page 973, Table 5:

Under Events avoided/1000 schizophrenia patients (5 years): 18 should read 28.

Under Cost/metabolic syndrome avoided (5 years): −€2,860.52 should read −€1,852.73.






 

Other articles by Professor Giorgio Colombo

Cost-effectiveness analysis of initial HIV treatment under Italian guidelines


A cost–utility analysis of etanercept for the treatment of moderate-to-severe psoriasis in Italy
A cost-effectiveness analysis of different therapies in patients with chronic hepatitis B in Italy
An economic evaluation of aripiprazole vs olanzapine adapted to the Italian setting using outcomes of metabolic syndrome and risk for diabetes in patients with schizophrenia
Assessment of acceptability and ease of use of atovaquone/proguanil medication in subjects undergoing malaria prophylaxis
Candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) and resource utilization and costs in Italy
Cost–utility analysis of prophylaxis versus treatment on demand in severe hemophilia A
Cost-effectiveness analysis of electrochemotherapy with the Cliniporator™ vs other methods for the control and treatment of cutaneous and subcutaneous tumors
Moderate and severe plaque psoriasis: cost-of-illness study in Italy